Amputation · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events (participants) · people with critical limb ischaemia
PGE1 showed no clear difference in adverse events (participants) compared with inositol niacinate (low certainty).
1 finding from 1 review
Rest‐pain relief · people with critical limb ischaemia
PGE1 showed no clear difference in rest‐pain relief compared with inositol niacinate (low certainty).
1 finding from 1 review
Ulcer healing · people with critical limb ischaemia
PGE1 showed no clear difference in ulcer healing compared with inositol niacinate (low certainty).
1 finding from 1 review
Intervention not reported
Tumour response · ovarian carcinoma
1 finding from 1 review
Intervention not reported
Tumour response · ovarian carcinoma
1 finding from 1 review
Intervention not reported
Post‐immunotherapy treatment response · ovarian carcinoma
1 finding from 1 review
Intervention not reported
Survival · ovarian carcinoma
1 finding from 1 review
Intervention not reported
Survival · ovarian carcinoma
1 finding from 1 review
Intervention not reported
Antigen‐specific immunogenicity (humoral response) · ovarian carcinoma
1 finding from 1 review
Intervention not reported
Antigen‐specific immunogenicity (cellular response) · ovarian carcinoma
1 finding from 1 review
At least 50% reduction in pain · Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries
Intravenous diclofenac may leads to higher number of participants with at least 50% pain relief at 4 hours compared with placebo (low certainty).
2 findings from 1 review
Number of participants using rescue medication over 4 to 6 hours postinterventions · Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries
It is very uncertain whether intravenous diclofenac changes number of participants using rescue medication over 4 to 6 hours… compared with another NSAID (very low certainty).
1 finding from 1 review
Number of participants reporting an adverse event · Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries
Intravenous diclofenac showed no clear difference in number of participants reporting any adverse event compared with another NSAID (low certainty).
1 finding from 1 review
Number of participants experiencing any serious adverse events · Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries
Intravenous diclofenac showed no clear difference in number of participants experiencing a serious adverse event compared with another NSAID (low certainty).
1 finding from 1 review
Median (mean) time to use of rescue medication · Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries
1 finding from 1 review
Number of participants using rescue medication over 4 to 6 hours postinterventions · Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries
Intravenous diclofenac may leads to lower number of participants using rescue medication over 4 to 6 hours… compared with placebo (low certainty).
1 finding from 1 review
Number of participants reporting an adverse event · Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries
Intravenous diclofenac showed no clear difference in number of participants reporting any adverse event compared with placebo (low certainty).
1 finding from 1 review
Number of participants experiencing any serious adverse events · Adults (mean study ages 25 to 55 years) with acute postoperative pain after dental, mixed minor, abdominal, or orthopedic surgeries
Intravenous diclofenac showed no clear difference in number of participants experiencing a serious adverse event compared with placebo (low certainty).
1 finding from 1 review